Why the study?
Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease compared to those without?
Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease compared to those without?
Echocardiographic epicardial fat thickness is significantly increased in patients with coronary artery disease, suggesting it may serve as a useful non-invasive marker for CAD.
Echocardiographic EFT may aid CAD detection in practice; confirms association in meta-analysis but leaves clinical adoption open pending prospective validation.
Background: The relation of epicardial fat thickness (EFT) to coronary artery disease (CAD) has recently been reported in multiple studies. Echocardiography is a safe and relatively inexpensive and accessible approach to assess regional EFT, which can be performed easily in many centers. Objective: To determine the association between echocardiographic EFT and the presence or the absence of CAD. Methods: This was a systematic review and meta-analysis conducted on literature available in electronic databases up to March 2018. The articles measuring EFT by echocardiography in the right ventricular (RV) free wall were included in the study. The quality of the enrolled items was assessed using the Methodological Index for Non-Randomized Studies (MINORS) checklist. The analyses were performed using the Comprehensive Meta-Analysis version 2 software. Cochran's Q test and I 2 index were used to evaluate heterogeneity. Results: This meta-analysis was performed on 13 studies involving 2,436 patients (1,622 with CAD, and 814 without CAD). The maximum EFT reported by echocardiography was 12.92.7 mm in the CAD group and 8.42.5 mm in the non-CAD group. The minimum EFT reported by echocardiography was 2.21.8 mm in the CAD group and 1.81.4 mm in the non-CAD group. The heterogeneity was found among the researched studies (I 2 =91.8%, p=0.000, Q-value=146.43, df [Q] =12) using the random effect model. The patients with CAD had a significantly higher echocardiographic EFT than those without CAD (SMD=1.03, 95% CI= 0.70-1.37, p=0.000).
No takes yet. Share an insight, caveat, or question.
Ansari et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: